Concepedia

Troy Bloom

TB

Statistics

Publications

7

Citations

1.4K

H-Index

7

Active since

2001

Affiliations

Harvard University(Current)

Merrimack Pharmaceuticals (United States)

Roswell Park Comprehensive Cancer Center

Massachusetts General Hospital

Acceleron Pharma (United States)

Troy Bloom is an author at Harvard University specializing in oncology, medicine, and molecular oncology.

Publications per year

2001–2022

7

Publications

7

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies

Doron Lipson, Marzia Capelletti, Roman Yelensky et al. · Nature Medicine · 2012 · 869 citations

Medicine, Molecular Genetics, Oncology +16

The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE

James B. Rottman, Tammy Smith, James R. Tonra et al. · Nature Immunology · 2001 · 267 citations

Life Sciences, Immunology, Pathobiology +14

Sotatercept analog suppresses inflammation to reverse experimental pulmonary arterial hypertension

Sachindra Raj Joshi, Jun Liu, Troy Bloom et al. · Scientific Reports · 2022 · 100 citations · Full text

Life Sciences, Cardiology, Immunology +17

Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer

Adam J. Camblin, Emily A. Pace, Sharlene Adams et al. · Clinical Cancer Research · 2018 · 57 citations

Medicine, Oncology, Pharmacology +17

ActRIIB:ALK4-Fc alleviates muscle dysfunction and comorbidities in murine models of neuromuscular disorders

Jia Li, Maureen Fredericks, M. Cannell et al. · Journal of Clinical Investigation · 2021 · 34 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

1–5 of 7